Our clinics were asked to treat three attacks with each medication and then fill out a preference trial (cross-over study).
Unknown Phase
A preference trial with rizatriptan 10 mg and ibuprofen 400 mg in migraine patients in the general practice.
Active, not recruitingNL-OMON28934
Start: 2005-03-23Target: 35Updated: 2024-02-28
A preference trial with naratriptan 2,5 mg and paracetamol 1000 mg in migraine patients in the general practice.
Active, not recruitingNL-OMON22893
Start: 2005-01-01Target: 40Updated: 2024-02-28